In this section, we discuss how the VEGF:VEGFR system is involved in obesity, with regards to its role in angiogenesis, lymphangiogenesis, adipogenesis, and macrophage specification, and the current state of development of VEGF/VEGFR-targeted therapies for treating obesity. The gene discussed is KDR; the disease is obesity due to melanocortin 4 receptor deficiency.